Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections

Adam E. Fleischer, James S. Wrobel, Andrea Leonards, Scott Berg, Daniel P. Evans, Robert L. Baron, David G Armstrong

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Our aim was to determine whether post-treatment laboratory values could help to predict the clinical response in patients with advanced diabetic foot infections. One hundred and three consecutive patients hospitalized for moderate or severe diabetic foot infections at a large, university-affiliated hospital were identified and their records retrospectively reviewed. Definitive therapy during each patient's hospital course was defined as any foot surgery when additional major surgery was not anticipated or when a course of deep soft tissue and/or bone culture-specific antibiotics had been initiated. The clinical response was assessed at 90 days after the start of definitive therapy. A poor response was recognized as persistent infection at the initial or a contiguous site or when unplanned revision surgery or amputation was subsequently required. The peripheral white blood cell count, neutrophil count, erythrocyte sedimentation rate, and C-reactive protein levels measured shortly after initiating definitive therapy (i.e., post-treatment) were examined for their association with the clinical response using logistic regression models. A total of 38 patients with the complete compliment of laboratory and clinical follow-up aged 59.7 ± 12.3 years with a diabetes duration of 13.3 ± 9.1 years were included. Leukocytosis, defined as a white blood cell count >11,000 cells/μL, observed an average of 3 ± 1.4 days after treatment, was the single most important marker for predicting a poor clinical response, and the only significant study variable in both univariate and multivariate analyses (multivariate odds ratio 9.7, 95% confidence interval 1.0 to 92, p = .048). We conclude that leukocytosis observed shortly after initiating definitive therapy is predictive of an unfavorable clinical response by 90 days.

Original languageEnglish (US)
Pages (from-to)541-546
Number of pages6
JournalJournal of Foot and Ankle Surgery
Volume50
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Diabetic Foot
Leukocytosis
Infection
Leukocyte Count
Therapeutics
Logistic Models
Blood Sedimentation
Reoperation
Amputation
C-Reactive Protein
Foot
Neutrophils
Multivariate Analysis
Odds Ratio
Confidence Intervals
Anti-Bacterial Agents
Bone and Bones

Keywords

  • Diabetes mellitus
  • Foot
  • Length of stay
  • Logistic regression
  • Prognosis
  • Surgery
  • White blood cell count

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections. / Fleischer, Adam E.; Wrobel, James S.; Leonards, Andrea; Berg, Scott; Evans, Daniel P.; Baron, Robert L.; Armstrong, David G.

In: Journal of Foot and Ankle Surgery, Vol. 50, No. 5, 09.2011, p. 541-546.

Research output: Contribution to journalArticle

Fleischer, Adam E. ; Wrobel, James S. ; Leonards, Andrea ; Berg, Scott ; Evans, Daniel P. ; Baron, Robert L. ; Armstrong, David G. / Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections. In: Journal of Foot and Ankle Surgery. 2011 ; Vol. 50, No. 5. pp. 541-546.
@article{2846aeb012794915ae71158602d5bc2c,
title = "Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections",
abstract = "Our aim was to determine whether post-treatment laboratory values could help to predict the clinical response in patients with advanced diabetic foot infections. One hundred and three consecutive patients hospitalized for moderate or severe diabetic foot infections at a large, university-affiliated hospital were identified and their records retrospectively reviewed. Definitive therapy during each patient's hospital course was defined as any foot surgery when additional major surgery was not anticipated or when a course of deep soft tissue and/or bone culture-specific antibiotics had been initiated. The clinical response was assessed at 90 days after the start of definitive therapy. A poor response was recognized as persistent infection at the initial or a contiguous site or when unplanned revision surgery or amputation was subsequently required. The peripheral white blood cell count, neutrophil count, erythrocyte sedimentation rate, and C-reactive protein levels measured shortly after initiating definitive therapy (i.e., post-treatment) were examined for their association with the clinical response using logistic regression models. A total of 38 patients with the complete compliment of laboratory and clinical follow-up aged 59.7 ± 12.3 years with a diabetes duration of 13.3 ± 9.1 years were included. Leukocytosis, defined as a white blood cell count >11,000 cells/μL, observed an average of 3 ± 1.4 days after treatment, was the single most important marker for predicting a poor clinical response, and the only significant study variable in both univariate and multivariate analyses (multivariate odds ratio 9.7, 95{\%} confidence interval 1.0 to 92, p = .048). We conclude that leukocytosis observed shortly after initiating definitive therapy is predictive of an unfavorable clinical response by 90 days.",
keywords = "Diabetes mellitus, Foot, Length of stay, Logistic regression, Prognosis, Surgery, White blood cell count",
author = "Fleischer, {Adam E.} and Wrobel, {James S.} and Andrea Leonards and Scott Berg and Evans, {Daniel P.} and Baron, {Robert L.} and Armstrong, {David G}",
year = "2011",
month = "9",
doi = "10.1053/j.jfas.2011.04.023",
language = "English (US)",
volume = "50",
pages = "541--546",
journal = "Journal of Foot and Ankle Surgery",
issn = "1067-2516",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Post-treatment Leukocytosis Predicts an Unfavorable Clinical Response in Patients with Moderate to Severe Diabetic Foot Infections

AU - Fleischer, Adam E.

AU - Wrobel, James S.

AU - Leonards, Andrea

AU - Berg, Scott

AU - Evans, Daniel P.

AU - Baron, Robert L.

AU - Armstrong, David G

PY - 2011/9

Y1 - 2011/9

N2 - Our aim was to determine whether post-treatment laboratory values could help to predict the clinical response in patients with advanced diabetic foot infections. One hundred and three consecutive patients hospitalized for moderate or severe diabetic foot infections at a large, university-affiliated hospital were identified and their records retrospectively reviewed. Definitive therapy during each patient's hospital course was defined as any foot surgery when additional major surgery was not anticipated or when a course of deep soft tissue and/or bone culture-specific antibiotics had been initiated. The clinical response was assessed at 90 days after the start of definitive therapy. A poor response was recognized as persistent infection at the initial or a contiguous site or when unplanned revision surgery or amputation was subsequently required. The peripheral white blood cell count, neutrophil count, erythrocyte sedimentation rate, and C-reactive protein levels measured shortly after initiating definitive therapy (i.e., post-treatment) were examined for their association with the clinical response using logistic regression models. A total of 38 patients with the complete compliment of laboratory and clinical follow-up aged 59.7 ± 12.3 years with a diabetes duration of 13.3 ± 9.1 years were included. Leukocytosis, defined as a white blood cell count >11,000 cells/μL, observed an average of 3 ± 1.4 days after treatment, was the single most important marker for predicting a poor clinical response, and the only significant study variable in both univariate and multivariate analyses (multivariate odds ratio 9.7, 95% confidence interval 1.0 to 92, p = .048). We conclude that leukocytosis observed shortly after initiating definitive therapy is predictive of an unfavorable clinical response by 90 days.

AB - Our aim was to determine whether post-treatment laboratory values could help to predict the clinical response in patients with advanced diabetic foot infections. One hundred and three consecutive patients hospitalized for moderate or severe diabetic foot infections at a large, university-affiliated hospital were identified and their records retrospectively reviewed. Definitive therapy during each patient's hospital course was defined as any foot surgery when additional major surgery was not anticipated or when a course of deep soft tissue and/or bone culture-specific antibiotics had been initiated. The clinical response was assessed at 90 days after the start of definitive therapy. A poor response was recognized as persistent infection at the initial or a contiguous site or when unplanned revision surgery or amputation was subsequently required. The peripheral white blood cell count, neutrophil count, erythrocyte sedimentation rate, and C-reactive protein levels measured shortly after initiating definitive therapy (i.e., post-treatment) were examined for their association with the clinical response using logistic regression models. A total of 38 patients with the complete compliment of laboratory and clinical follow-up aged 59.7 ± 12.3 years with a diabetes duration of 13.3 ± 9.1 years were included. Leukocytosis, defined as a white blood cell count >11,000 cells/μL, observed an average of 3 ± 1.4 days after treatment, was the single most important marker for predicting a poor clinical response, and the only significant study variable in both univariate and multivariate analyses (multivariate odds ratio 9.7, 95% confidence interval 1.0 to 92, p = .048). We conclude that leukocytosis observed shortly after initiating definitive therapy is predictive of an unfavorable clinical response by 90 days.

KW - Diabetes mellitus

KW - Foot

KW - Length of stay

KW - Logistic regression

KW - Prognosis

KW - Surgery

KW - White blood cell count

UR - http://www.scopus.com/inward/record.url?scp=80051948354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051948354&partnerID=8YFLogxK

U2 - 10.1053/j.jfas.2011.04.023

DO - 10.1053/j.jfas.2011.04.023

M3 - Article

VL - 50

SP - 541

EP - 546

JO - Journal of Foot and Ankle Surgery

JF - Journal of Foot and Ankle Surgery

SN - 1067-2516

IS - 5

ER -